Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Christie currently holds 10,891 shares of Pacira BioSciences, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Christie has been a net neutral trader of PCRX stock. They have purchased $0 and sold $0 worth of shares.
Christopher Christie's most recent insider trade was on Jun 10, 2026, when they sold 10,891 shares at $0.00 per share.
Christopher Christie serves as Executive at Pacira BioSciences, Inc. (PCRX). They have executed 8 insider transactions totaling $0 over their tenure at the company.
Christopher Christie holds the position of Executive at Pacira BioSciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Christopher Christie has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Christopher Christie was on Jun 10, 2026, when they purchased $0 worth of PCRX shares. This transaction involved 10,891 shares at N/A per share.
Christopher Christie currently owns 10,891 shares of Pacira BioSciences, Inc. (PCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Christie's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Christie has 8 Form 4 filings on record as an insider at Pacira BioSciences, Inc..
Set alerts for Christopher Christie and 40,000+ other insiders.